Open Access

[Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance

  • Authors:
    • Xinjiang Zhu
    • Jian Liu
    • Xiaoyang Xu
    • Chundong Zhang
    • Dongqiu Dai
  • View Affiliations

  • Published online on: January 24, 2022     https://doi.org/10.3892/ijo.2022.5313
  • Article Number: 23
  • Copyright : © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

March-2022
Volume 60 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhu X, Liu J, Xu X, Zhang C and Dai D: [Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance. Int J Oncol 60: 23, 2022
APA
Zhu, X., Liu, J., Xu, X., Zhang, C., & Dai, D. (2022). [Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance. International Journal of Oncology, 60, 23. https://doi.org/10.3892/ijo.2022.5313
MLA
Zhu, X., Liu, J., Xu, X., Zhang, C., Dai, D."[Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance". International Journal of Oncology 60.3 (2022): 23.
Chicago
Zhu, X., Liu, J., Xu, X., Zhang, C., Dai, D."[Corrigendum] The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance". International Journal of Oncology 60, no. 3 (2022): 23. https://doi.org/10.3892/ijo.2022.5313